These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2659740

  • 1. Combined alpha-2C-interferon/VMCP polychemotherapy versus VMCP polychemotherapy as induction therapy in multiple myeloma: a prospective randomized trial.
    Scheithauer W, Cortelezzi A, Fritz E, Kührer I, Polli E, Baldini L, Ludwig H.
    J Biol Response Mod; 1989 Apr; 8(2):109-15. PubMed ID: 2659740
    [Abstract] [Full Text] [Related]

  • 2. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
    Oken MM, Leong T, Lenhard RE, Greipp PR, Kay NE, Van Ness B, Keimowitz RM, Kyle RA.
    Cancer; 1999 Sep 15; 86(6):957-68. PubMed ID: 10491521
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience.
    Cohen AM, Meytes D, Many A, Brenner B, Aghai E, Shaklai M, Kaufman S, Shtalrid M, Attias D, Manor Y.
    Isr J Med Sci; 1995 Oct 15; 31(10):604-10. PubMed ID: 7591683
    [Abstract] [Full Text] [Related]

  • 6. Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial.
    Ludwig H, Cortelezzi A, Scheithauer W, Van Camp BG, Kuzmits R, Fillet G, Peetermans M, Polli E, Flener R.
    Eur J Cancer Clin Oncol; 1986 Sep 15; 22(9):1111-6. PubMed ID: 3536528
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomized study comparing VMCP and MMPP in the treatment of multiple myeloma.
    Nagura E, Ichikawa A, Kamiya O, Kato R, Utsumi M, Tanaka M, Takeyama H, Shimizu K, Kobayashi M, Naito K, Nishiwaki H, Mizuno H, Hirabayashi N, Nitta M, Kato Y, Shibata T, Hotta T, Kawashima K, Saito H.
    Cancer Chemother Pharmacol; 1997 Sep 15; 39(4):279-85. PubMed ID: 9025767
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: interim results.
    Ludwig H, Cohen AM, Huber H, Nachbaur D, Jungi WF, Senn H, Günczler P, Schüller J, Eckhardt S, Seewann HL.
    Eur J Cancer; 1991 Sep 15; 27 Suppl 4():S40-5. PubMed ID: 1799476
    [Abstract] [Full Text] [Related]

  • 12. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
    Abramson N, Lurie P, Mietlowski WL, Schilling A, Bennett JM, Horton J.
    Cancer Treat Rep; 1982 Jun 15; 66(6):1273-7. PubMed ID: 7044535
    [Abstract] [Full Text] [Related]

  • 13. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D, Bosković D, Radosević N, Elezović I, Tomin D, Gotić M, Antunović P.
    Srp Arh Celok Lek; 1996 Jun 15; 124(11-12):292-6. PubMed ID: 9132962
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Chemotherapy and immunomodulating treatment of patients with multiple myeloma].
    Kraj M, Dmoszyńska A, Maj S, Kowalewski J, Rostkowska J, Pogłód R, Sokołowska B, Mendek-Czajkowska E, Kurowska M, Sokołowska U.
    Acta Haematol Pol; 1991 Jun 15; 22(1):4-20. PubMed ID: 1823965
    [Abstract] [Full Text] [Related]

  • 17. Results and further perspectives of plasmocytoma chemotherapy.
    Sakalová A, Hrubisko M, Gazová S, Steruská M, Prümmerová J.
    Neoplasma; 1986 Jun 15; 33(2):251-8. PubMed ID: 3520353
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Progress in the treatment of multiple myeloma].
    Wada M, Mizoguchi H.
    Gan To Kagaku Ryoho; 1997 Jul 15; 24(9):1079-88. PubMed ID: 9239160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.